ENTERACTIVE INC /DE/
SC 13E4/A, 1997-12-18
PREPACKAGED SOFTWARE
Previous: INKINE PHARMACEUTICAL CO INC, S-3, 1997-12-18
Next: ICN PHARMACEUTICALS INC, 8-K, 1997-12-18



                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549


                                 SCHEDULE 13E-4/A

                          ISSUER TENDER OFFER STATEMENT
      (PURSUANT TO SECTION 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934)

                                (Amendment No. 1)

                                ENTERACTIVE, INC.
- --------------------------------------------------------------------------------
                                (Name of Issuer)

                                ENTERACTIVE, INC.
- --------------------------------------------------------------------------------
                      (Name of Person(s) Filing Statement)

            Common Stock Purchase Warrant Expiring December 13, 2001
- --------------------------------------------------------------------------------
                         (Title of Class of Securities)

                      (CUSIP Number of Class of Securities)

                                  Andrew Gyenes
                                Enteractive, Inc.
                        110 West 40th Street, Suite 2100
                            New York, New York 10018
                                 (212) 221-6559

   (Name, Address and Telephone Number of Person Authorized to Receive Notices
         and Communications on Behalf of the Person(s) Filing Statement)

                                    Copy to:

                              Steven Wolosky, Esq.
                          Kenneth A. Schlesinger, Esq.
                     Olshan Grundman Frome & Rosenzweig LLP
                                 505 Park Avenue
                               New York, NY 10022
                                 (212) 753-7200
                            Facsimile: (212) 755-1467

                                November 19, 1997
- --------------------------------------------------------------------------------
     (Date Tender Offer First Published, Sent or Given to Security Holders)


                            CALCULATION OF FILING FEE


- --------------------------------------------------------------------------------
       Transaction Valuation(1)                        Amount of Filing Fee
- --------------------------------------------------------------------------------
             $1,750,000                                      $350.00
- --------------------------------------------------------------------------------

/  /     Check  box if any  part  of the  fee is  offset  as  provided  by  Rule
         0-11(a)(2)  and identify the filing with which the  offsetting  fee was
         previously paid. Identify the previous filing by registration statement
         number, or the form or schedule and the date of its filing.


Amount previously paid:     350.00         Filing party:          N/A
                        ----------------                 -----------------------


Form or registration no.: Schedule 13E-4   Date filed:  November 26,1997
                          --------------                ------------------------

- --------
(1)      Estimated solely for purposes of calculating the fee in accordance with
         Rule 0-11 under the Securities Exchange Act of 1934, as amended. Based
         upon the book value of the Warrants $.416, multiplied by the number of
         Warrants that the issuer, Enteractive, Inc. (the "Company") is offering
         to acquire (4,200,000) Warrants).


<PAGE>
         This  constitutes  Amendment No. 1 ("Amendment  No. 1") to the Schedule
13E-4 filed by the  undersigned  (the  "Schedule  13E-4").  This Amendment No. 1
supplements the Schedule 13E-4 as specifically set forth. All capitalized  terms
used herein which are not otherwise defined have the meaning ascribed to them in
the Schedule 13E-4.

         This Amendment to Schedule 13E-4 is being filed to amend Item 1(b) and
Item 9 so that they read in their entirety as follows:

Item 1.  Security and Issuer.

                  (b) The  Company is seeking  to acquire  all of the  4,200,000
outstanding  Common Stock Purchase  Warrants  expiring on December 13, 2001 (the
"Warrants").  The Company is offering to exchange one share of its Common Stock,
$.01 par  value  per share  (the  "Common  Stock"),  for 2.8  Warrants  properly
tendered and not validly withdrawn, upon the terms and subject to the conditions
set forth in the Offering Circular of the Company,  dated November 19, 1997 (the
"Offering  Circular"),  and the related  Letter of  Transmittal  (the  "Exchange
Offer"). In connection with the Exchange Offer and as a condition to the Closing
of the Exchange  Offer,  the Company is requiring that all of the holders of the
Company's Class A Convertible  Preferred Stock (the "Preferred  Stock") agree to
modify  the terms of the  Preferred  Stock to delay the date when the  Preferred
Stock can first be  converted  into Common  Stock of the Company  from April 30,
1998 to June 30, 1999 (the "Delayed Conversion Option"). In addition all holders
of the Preferred Stock who approve the above-referenced  proposal will receive a
special monthly interest payment equal to 12% per annum (or 1% per month) of the
stated value of the Preferred Stock ($1,250) for the period  commencing on April
30, 1998 and ending on the earlier of (i) June 30, 1999 or (ii) the  redemption,
if any, of the Preferred Stock. Copies of the Offering Circular, a supplement to
the  Offering  Circular and the Letter of  Transmittal  relating to the Exchange
Offer are filed herewith as Exhibits  (a)(1),  (a)(2) and (a)(3),  respectively.
Information  with respect to the number of Warrants  outstanding is set forth in
the Offering  Circular under "THE EXCHANGE  OFFER -- General -- Exchange  Offer"
and is incorporated herein by reference.  Officers,  directors and affiliates of
the Company that own Warrants may  participate in the Exchange Offer on the same
basis as all other holders of Warrants.  Definitive  information with respect to
their  participation  in the Exchange Offer will not be available to the Company
until the consummation thereof.

Item 9.  Material to be Filed as Exhibits.

                  (a)(1) Offering Circular dated November 19, 1997.*
                     (2) Supplement to Offering Circular
                     (3) Form of Letter of Transmittal.*
                     (4) Form of Press Release.*
                     (5) Form of letter to  Warrantholders  from the Chairman of
                         the Board and Chief  Executive  Officer of the  Company
                         dated November 19, 1997.


                                       -2-

<PAGE>



                     (6)   1997 Annual Report on Form 10-KSB.*
                     (7)   Quarterly Report on Form 10-QSB for the quarter ended
                           August 31, 1997.*


- --------------------------
*        Previously filed.

                  (b)-(f)  Not Applicable.


                                       -3-

<PAGE>
                                    SIGNATURE

         After due inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.



                                        ENTERACTIVE, INC.



                                        By: /s/ Andrew Gyenes
                                            ------------------------------
                                            Name:    Andrew Gyenes
                                            Title:   Chairman of the Board

Dated:  December 18, 1997

                                       -4-



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission